TLR2 and neoplasm: In this context, HMGB1 expressed on the surface of tumor-derived EVs can interact with TLR-2 on B cells, inducing the expression of T cell Immunoglobulin and Mucin domain 1 (TIM-1) on B cells via an MAPK-pathway-dependent mechanism.